These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3898001

  • 1. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
    Trachtman H, Zavilowitz B, Bennett B, Goldsmith DI.
    Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001
    [Abstract] [Full Text] [Related]

  • 2. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 3. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
    Ginevri F, Gusmano R, Oleggini R, Acerbo S, Bertelli R, Perfumo F, Cercignani G, Allegrini S, D'Allegri F, Ghiggeri G.
    Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
    [Abstract] [Full Text] [Related]

  • 4. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
    Trachtman H, Del Pizzo R, Valderrama E, Gauthier B.
    Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316
    [Abstract] [Full Text] [Related]

  • 5. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
    Shinosaki T, Takagawa I, Sunagawa N, Yonetani Y, Kurihara H.
    Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
    Pedraza-Chaverrí J, Cruz C, Chávez MT, Ibarra-Rubio ME, Tapia E, Peña JC.
    Rev Invest Clin; 1990 Apr; 42(3):210-6. PubMed ID: 2270368
    [Abstract] [Full Text] [Related]

  • 7. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 8. Effect of captopril on urinary excretion of renin and angiotensinogen in aminonucleoside nephrosis.
    Pedraza-Chaverri J, Cruz C, Sandoval AA, Tapia E, Peña JC.
    Ren Fail; 1992 Sep; 14(2):155-9. PubMed ID: 1636021
    [Abstract] [Full Text] [Related]

  • 9. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R, Veress AT, Sonnenberg H.
    Pharmacology; 1989 Sep; 38(4):214-25. PubMed ID: 2526952
    [Abstract] [Full Text] [Related]

  • 10. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR, Meline JA, Ni RX, Keys M, Wu CH.
    Am J Pathol; 1987 Oct; 129(1):133-9. PubMed ID: 3499082
    [Abstract] [Full Text] [Related]

  • 11. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD, Bertram JF, Ryan GB.
    Exp Nephrol; 1995 Oct; 3(5):270-9. PubMed ID: 7583048
    [Abstract] [Full Text] [Related]

  • 12. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE, Ou SL, Velosa JA, Shah SV, Dousa TP.
    J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
    Kimura K, Endou H, Sakai F.
    J Toxicol Sci; 1979 Feb; 4(1):1-10. PubMed ID: 480401
    [Abstract] [Full Text] [Related]

  • 14. Renin-sodium profile in experimental nephrosis induced by puromycin aminonucleoside.
    Sagae Y, Matsumoto Y, Unno K.
    J Pharmacobiodyn; 1983 Jul; 6(7):475-80. PubMed ID: 6358456
    [Abstract] [Full Text] [Related]

  • 15. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Jul; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 16. Effect of a novel free radical scavenger, edaravone, on puromycin aminonucleoside induced nephrosis in rats.
    Someya T, Kaneko K, Yamada T, Yamashiro Y.
    Pediatr Nephrol; 2005 Oct; 20(10):1430-4. PubMed ID: 16079985
    [Abstract] [Full Text] [Related]

  • 17. Urinary kallikrein in experimental renal disease.
    Glasser RJ, Michael AF.
    Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467
    [Abstract] [Full Text] [Related]

  • 18. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985 Jun; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

  • 19. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G, Imberti L, Rossini M, Morelli C, Carminati C, Cattaneo GM, Bertani T.
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [Abstract] [Full Text] [Related]

  • 20. Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
    Nagase M, Kumagai H, Honda N.
    Ren Physiol; 1984 Jan; 7(4):218-26. PubMed ID: 6473895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.